Literature DB >> 7016966

Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.

G Gragnoli, A M Signorini, I Tanganelli.   

Abstract

Plasma levels of immunoreactive insulin (IRI), C-peptide and glucagon were assayed in 16 patients with liver cirrhosis and 9 control subjects after an oral glucose load (OGTT). Nine of the cirrhotics showed glucose intolerance, the remaining 7 cases showed normal OGTT. Both groups of cirrhotics showed high IRI and C-peptide values in basal conditions; peaks of these parameters, higher than those observed in the control subjects, were found during the OGTT. The C-peptide/IRI ratio, which was lower than normal both during fasting and after glucose load, presented the lowest values in patients with normal OGTT. In the conditions adopted for this study, glucagon showed higher plasma levels in all the cirrhotics studied than those found in the controls, but the highest levels were found in patients with normal OGTT. It can be concluded that the high levels of insulin found in liver cirrhosis are due to a beta-pancreatic hypersecretion (high C-peptide levels) but are also maintained by a decreased hepatic degradation of the hormone (C-peptide/IRI ratio below normal). Hyperglucagonemia is not the chief factor in determining the insulin-resistance observed in liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016966     DOI: 10.1007/BF03349405

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Potassium depletion in hepatic cirrhosis. A reversible cause of impaired growth-hormone and insulin response to stimulation.

Authors:  S Podolsky; H J Zimmerman; B A Burrows; J A Cardarelli; C G Pattavina
Journal:  N Engl J Med       Date:  1973-03-29       Impact factor: 91.245

4.  Glucose homeostasis in viral hepatitis.

Authors:  P Felig; W V Brown; R A Levine; G Klatskin
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

5.  [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].

Authors:  G Gragnoli; A Pupillo; M Montagnani; P F Bayeli
Journal:  Atti Accad Fisiocrit Siena Med Fis       Date:  1968

6.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

Review 7.  [Diabetes mellitus secondary to liver diseases. A review (author's transl)].

Authors:  J Guillon; B Charbonnel
Journal:  Diabete Metab       Date:  1975-09

8.  Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.

Authors:  R S Sherwin; M Fisher; J Bessoff; N Snyder; R Hendler; H O Conn; P Felig
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

9.  Degradation and secretion of insulin in hepatic cirrhosis.

Authors:  Y Iwasaki; A Ohkubo; H Kajinuma; Y Akanuma; K Kosaka
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

10.  Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?

Authors:  D G Johnson; K G Alberti; O K Faber; C Binder
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

View more
  2 in total

1.  Plasma betatrophin levels in patients with liver cirrhosis.

Authors:  Maria Teresa Arias-Loste; Maria Teresa García-Unzueta; Susana Llerena; Paula Iruzubieta; Angela Puente; Joaquín Cabezas; Carmen Alonso; Antonio Cuadrado; José Antonio Amado; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

2.  Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens.

Authors:  Masahiro Sakata; Akihiko Kawahara; Takumi Kawaguchi; Jun Akiba; Tomoki Taira; Eitaro Taniguchi; Mitsuhiko Abe; Hironori Koga; Masayoshi Kage; Michio Sata
Journal:  J Gastroenterol       Date:  2012-07-12       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.